Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery India 2013

Drug Discovery India 2013 Agenda



Co-Located Conference Agendas

Microfluidics & Lab on a Chip India | Genomics and Proteomics Research | Drug Discovery India 2013 | 

Print Agenda

Friday, 27 September 2013

08:00

Registration

08:50

Welcome Address

09:00

Address by the Conference Chair

09:05

M.N. VidyashankarPlenary Presentation

Inaugural Address
M.N. Vidyashankar, Additional Chief Secretary, Government of Karnatka, India

09:30

Tushar ChakrabortyKeynote Presentation

Plenary Presentation:Challenges in Drug Discovery - From Natural Products to Designer Molecules
Tushar Chakraborty, Director, Central Drug Research Institute, India

10:10

Coffee Break and Networking


Session 1: Renaissance in Pharmacognosy I Session Chair: Dr. Krishna Kodukula

10:30

Shifting Paradigm for Development of Traditional Medicine – Farm to Pharma
Pulok K Mukherjee, Director- School of Natural Product Studies, Jadavpur University, India

10:50

Advances in Natural Product-based Drug Discovery: Success Story of Swertiamarin
Ramesh Goyal, Distinguished Professor, Ahmedabad University, India

11:10

Bhushan PatwardhanKeynote Presentation

Special Lecture: Pharmacognosy: Time to Refresh and Accelerate Drug Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India

 

11:30

Development of Novel Potential Cancer Therapeutics
Paturu Kondaiah, Professor, Indian Institute of Science, India


Session 2: Renaissance in Pharmacognosy II Session Chair: Dr. Kalpana Joshi

11:50

Modern Tools to Mine Traditional Medicine
Badireenath Konkimalla, Reader-F, National Institute of Science Education and Research, India

12:10

Drug Discovery from Natural Sources- Pre-clinical to Clinical
Pralhad Patki, Head, The Himalaya Drug, India

12:30

Commercial Use of Endophytic Fungi for Industrial Production of Bioactive Secondary Metabolites
Chelliah Jayabaskaran, Professor, Indian Institute of Science, India

12:50

Advanced Chemistry Development IncTechnology Spotlight:
Enabling Drug Discovery for Natural & Synthetic Products: A New Approach
K K Bhagchandani, Director, Advanced Chemistry Development Inc

13:05

Lunch and Networking


Session 3: Explorations in Chemical Biology Session Chair: Dr. Dipak Ramji

14:00

Atherosclerosis: New perspectives, Therapeutic Strategies and Translational Challenges
Dipak Ramji, Professor, Cardiff University, United Kingdom

14:20

Novel Translational Approach to Neurodegenerative Disease; Peptides Derived from the Activator of Neuronal Cell Cycle like Kinase (Cdk5) Prevented Alzheimer’s Disease (AD) Phenotypes in AD Model Mice.
Harish Pant, Senior Investigator, National Institute of Health, United States of America

14:40

Ascent of Coenzyme Q
T. Ramasarma, Professor, Indian Institute of Science, India

15:00

The Evaluation of the Effect of Fibrinolytic Drugs on the Vasopressin Elicited Phospholipase C Activity in the Goat Kidney
Manoj Tyagi, Professor of Pharmacology, Christian Medical College, India


Session 4: Screening Techniques in Drug Discovery Session Chair: Dr. G.N. Sastry

15:10

Anil MadanKeynote Presentation

New Generation Molecular Descriptors for Accelerating Drug Discovery Process
Anil Madan, Professor, Pandit B D Sharma University of Health Sciences, India

15:40

Virtual Screening Techniques in Lead Identification : What to Expect ?
G Sastry, Sr Principal Scientist, Indian Institute of Chemical Technology, India

 

16:00

Coffee Break and Networking


Session 5: Advances in Chemo-and Bio-Informatics Session Chair: Dr. Harish Pant

16:20

OpenSource Chemoinformatics Tools and Methods for Virtual Screening
M Karthikeyan, Chemoinformatics Scientist, National Chemical Laboratory, India

16:40

Genomic Approaches to Drug Discovery
Kalpana Joshi, Professor & Head, Sinhgad College of Engineering, India

17:00

SelectBioTechnology Spotlight:
Director, GVK Biosciences
, , SelectBio

17:20

Litao ZhangKeynote Presentation

Envisioning a Path to the Future
Litao Zhang, Vice President/Leads Discovery & Optimization, Bristol-Myers Squibb, United States of America

18:00

End of the Day

18:30

Drinks Reception and Networking in the Exhibition Area

Saturday, 28 September 2013

08:30

Walderez DutraKeynote Presentation

Plenary Presentation:Alternative Therapies in Cutaneous Leishmaniasis
Walderez Dutra, Professora Titular, Federal University of Minas Gerais, Brazil


Session 6: Rare and Neglected Diseases Session Chair: Dr. Swati Joshi

09:10

Krishna BanaudhaKeynote Presentation

Anti-Viral Drug Development: Strategies and Challenges
Krishna Banaudha, Associate Professor, The George Washington University, United States of America

09:30

Biodiversity, Chemical Diversity and Phytodrugs
Swati Joshi, Scientist F, National Chemical Laboratory, India

 

09:50

Challenges in Drug Development for Dengue Fever: Immunoregulatory Aspects Associated with Hemorrhagic Manifestations
Kenneth Gollob, Professor, Institute for Education and Research, Brazil

10:10

Repurposing Old Drugs for New Regimens for Tuberculosis
Amit Singhal, Senior Research Scientist, Agency for Science Technology & Research A*Star, Singapore

10:20

Coffee Break and Networking


Session 7: Novel Enabling Technologies Session Chair: Dr. Hakim Djaballah

10:40

Hakim DjaballahKeynote Presentation

Cell Based Assays in Drug Discovery: Changing The HTS Paradigm
Hakim Djaballah, CEO, Institute Pasteur - Korea, Korea South

11:10

Whole animal HTS: A Novel Antibacterial Drug Discovery Platform
Horst Flotow, Senior Project Manager, D3 (Drug Discovery and Development)e, Singapore

11:30

EU-OPENSCREEN – Building a Pan-European Resource and Infrastructure to Support Chemical Biology Research
Ronald Frank, Coordinator, The Leibniz Institute for Molecular Pharmacology, Germany

11:50

GE Healthcare LifescienceTechnology Spotlight:
Potential of Proteomics and Cellular Analysis in Drug Discovery and Early Toxicology Studies– GE Healthcare Integrated Platforms
Lalith Kishore, General Manager - Research Products, GE Healthcare Lifescience


Session 8: Drug Discovery Research-Trends and Opportunities Session Chair: Dr. Ronald Frank

12:10

Kattesh V. KattiKeynote Presentation

Green Nanotechnology Provides Unprecedented Opportunities In Drug Discovery
Kattesh V. Katti, Director, Institute of Green Nanotechnology / Radiology / Cancer Nanotechnology Platform, University of Missouri, United States of America

12:40

Novel Enabling Synthetic Strategies: Sustainable Technologies in Academic Drug Discovery Research".
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India

13:00

New Drug Discovery: Challenges and Opportunities-Industry Perspective
Balachandra Bandodkar, General Manager, Alkem Laboratories, China

13:20

Design of Drug Molecules in Reversing Multidrug Resistance in Cancer cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India

13:40

Lunch Break and Networking

14:40

Poster Session


Session 9: Collaborative Innovation in Biomedicine Session Chair: Dr. John Watson

15:00

Drug Discovery, Current and Future Perspectives
D Giles, Professor, Acharya Bm Reddy College of Pharmacy, India

15:20

Importance of Collaboration between Biopharma Industry and Academia for Human Resource Development
Ramesh Sane, Director, Guru Nanak Khalsa college of Art, Science & Commerce, India

15:40

Open Innovation through Industry and Academia collaboration
Manish Diwan, Associate Director, Daiichi Sankyo India Pharma Private Limited, India

15:50

Special Lecture: Non-profit Pharma: A New Paradigm for Innovation
Krishna Kodukula, Executive Director, CADRE, SRI International, United States of America

16:10

Coffee Break and Networking


Session 10: Panel Discussion- Current Trends in Contract Research Landscape Session Chair: Dr. M. Bhupathy

16:30

Current Trends in Contract Research Landscape
M Bhupathy, Executive Director, Amgen Inc, United States of America

16:31

Current Trends in Contract Research Landscape.
John Watson, Director, Promega Corporation, United States of America

16:32

Current Trends in Contract Research Landscape
Thomas Antony, Research Director, Aurigene Discovery Technologies Limited, India

16:33

Current Trends in Contract Research Landscape
Jayashree Aiyar, VP, Jubliant Biosys, India

16:34

Current Trends in Contract Research Landscape
Sudhir Singh, Senior Vice President, GVK Biosciences Inc, India

16:35

Current Trends in Contract Research Landscape
Manjunath Ramarao, Group Director and Head, Disease Sciences and Technology, Bristol-Myers Squibb India Pvt Ltd, India

16:36

Current Trends in Contract Research Landscape
Manoj Nerurkar, Chief Operating Officer, Syngene International, India

17:20

Poster Award Presentation & Closing Remarks by Conference Chair


Add to Calendar ▼2013-09-27 00:00:002013-09-28 00:00:00Europe/LondonDrug Discovery India 2013Drug Discovery India 2013 in Banglore, IndiaBanglore, IndiaSELECTBIOenquiries@selectbiosciences.com